Authors:
Jansen, WTM
Verheul, AFM
Veeneman, GH
van Boom, JH
Snippe, H
Citation: Wtm. Jansen et al., Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits, VACCINE, 20(1-2), 2001, pp. 19-21
Authors:
Liu, LJ
Watabe, S
Yang, J
Hamajima, K
Ishii, N
Hagiwara, E
Onari, K
Xin, KQ
Okuda, K
Citation: Lj. Liu et al., Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses, VACCINE, 20(1-2), 2001, pp. 42-48
Authors:
Finerty, S
Stokes, CR
Gruffydd-Jones, TJ
Hillman, TJ
Barr, FJ
Harbour, DA
Citation: S. Finerty et al., Targeted lymph node immunization can protect cats from a mucosal challengewith feline immunodeficiency virus, VACCINE, 20(1-2), 2001, pp. 49-58
Citation: A. Ghosh et al., Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections, VACCINE, 20(1-2), 2001, pp. 59-66
Citation: W. Matheis et al., The role of the adsorption process for production and control combined adsorbed vaccines, VACCINE, 20(1-2), 2001, pp. 67-73
Authors:
Atti, MLC
Salmaso, S
Cotter, B
Gallo, G
Alfarone, G
Pinto, A
Bella, A
von Hunolstein, C
Citation: Mlc. Atti et al., Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age, VACCINE, 20(1-2), 2001, pp. 74-79
Citation: Y. Shi et al., Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines, VACCINE, 20(1-2), 2001, pp. 80-85
Authors:
Dewulf, J
Leavens, H
Koenen, F
Mintiens, K
de Kruif, A
Citation: J. Dewulf et al., An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus, VACCINE, 20(1-2), 2001, pp. 86-91
Authors:
Madalinski, K
Sylvan, SPE
Hellstrom, U
Mikolajewicz, J
Zembrzuska-Sadkowska, E
Piontek, E
Citation: K. Madalinski et al., Antibody responses to preS components after immunization of children with low doses of BioHepB, VACCINE, 20(1-2), 2001, pp. 92-97
Authors:
Inagaki-Ohara, K
Iwasaki, T
Watanabe, D
Kurata, T
Nishiyama, Y
Citation: K. Inagaki-ohara et al., Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection, VACCINE, 20(1-2), 2001, pp. 98-104
Authors:
Nagata, T
Higashi, T
Aoshi, T
Suzuki, M
Uchijima, M
Koide, Y
Citation: T. Nagata et al., Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization, VACCINE, 20(1-2), 2001, pp. 105-114
Authors:
Moore, RJ
Lenghaus, C
Sheedy, SA
Doran, TJ
Citation: Rj. Moore et al., Improved vectors for expression library immunization - application to Mycoplasma hyopneumoniae infection in pigs, VACCINE, 20(1-2), 2001, pp. 115-120
Authors:
Yura, M
Takahashi, I
Terawaki, S
Hiroi, T
Kweon, MN
Yuki, Y
Kiyono, H
Citation: M. Yura et al., Nasal administration of cholera toxin (CT) suppresses clinical signs of experimental autoimmune encephalomyelitis (EAE), VACCINE, 20(1-2), 2001, pp. 134-139
Citation: Bj. Zheng et al., A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model, VACCINE, 20(1-2), 2001, pp. 140-147
Citation: Wm. Li et al., Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes, VACCINE, 20(1-2), 2001, pp. 148-157
Authors:
Rimmelzwaan, GF
Baars, M
van Amerongen, G
van Beek, R
Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses, VACCINE, 20(1-2), 2001, pp. 158-163
Authors:
Hedlund, J
Langer, B
Konradsen, HB
Ortqvist, A
Citation: J. Hedlund et al., Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL-12 treatment in humans vaccinated with pneumococcal polysaccharide, VACCINE, 20(1-2), 2001, pp. 164-169
Authors:
Mauch, C
Grimm, C
Meckel, S
Wands, JR
Blum, HE
Roggendorf, A
Geissler, M
Citation: C. Mauch et al., Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice, VACCINE, 20(1-2), 2001, pp. 170-180
Authors:
Straubinger, RK
Rao, TD
Davidson, E
Summers, BA
Jacobson, RH
Frey, AB
Citation: Rk. Straubinger et al., Protection against tick-transmitted Lyme disease in dogs vaccinated with amultiantigenic vaccine, VACCINE, 20(1-2), 2001, pp. 181-193
Authors:
Nurkka, A
Ahman, H
Yaich, M
Eskola, J
Kayhty, H
Citation: A. Nurkka et al., Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT, VACCINE, 20(1-2), 2001, pp. 194-201
Authors:
Bos, JM
Rumke, HC
Welte, R
Postma, MJ
Jager, JC
Citation: Jm. Bos et al., Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program, VACCINE, 20(1-2), 2001, pp. 202-207